Anise Kachadourian
Hematology & Oncology · Roselle, NJNPI 1750349395
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (55.9%), consulting fees and education — rather than concentrated in one kind of arrangement. 27 manufacturers reported payments, led by AstraZeneca at 42.3% of the total. Reporting peaked in 2019 at $2,719 and has fallen 92.7% since, to $197 in 2023.
Across 110 payments — averaging $51.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- E.r. Squibb & Sons, L.L.C.$1K
- Incyte Corporation$519
- Takeda Pharmaceuticals U.S.A., Inc.$262
- Johnson & Johnson$204
- Collegium Pharmaceutical, Inc.$177
- plus $958 from 21 others
What the payments were for
- Consulting fees$2,30040%
- Food & beverage$3,17856%
- Education$2124%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 7 | $2,406 |
| E.r. Squibb & Sons, L.L.C. | 20 | $1,165 |
| Incyte Corporation | 9 | $519 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $262 |
| Johnson & Johnson(2 entities) | 9 | $204 |
| Collegium Pharmaceutical, Inc. | 13 | $177 |
| Novartis | 9 | $136 |
| Bristol Myers Squibb | 2 | $113 |
| W. L. Gore & Associates, Inc. | 1 | $89 |
| Pfizer | 5 | $87 |
| Exelixis Inc. | 5 | $85 |
| Amgen | 5 | $65 |
| Sanofi | 4 | $58 |
| Agios Pharmaceuticals, Inc. | 1 | $56 |
| GSK | 3 | $44 |
| Pharmacosmos Therapeutics Inc. | 1 | $37 |
| Array Biopharma Inc | 2 | $35 |
| Bayer | 1 | $20 |
| Daiichi Sankyo Inc. | 1 | $19 |
| Partner Therapeutics, Inc. | 1 | $18 |
| Seagen Inc. | 1 | $15 |
| Rigel Pharmaceuticals, Inc. | 1 | $15 |
| Beigene USA, Inc. | 1 | $15 |
| Puma Biotechnology, Inc. | 1 | $14 |
| Astellas Pharma US Inc | 1 | $14 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $13 |
| Regeneron Healthcare Solutions, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,690 in reported general payments places this provider in the 60th percentile of 362 hematology & oncology providers in New Jersey.
Other hematology & oncology in Roselle
- Robert SpiegelWestfield$864K
- Amit PatelJersey City$770K
- Joshua StraussSpringfield$739K
- Charles FarberMorristown$609K
- Michael ScolaMorristown$506K
- Eshan PatelSomerville$420K
- Arturo Loaiza-BonillaPennington$406K
- Ashish ShahSpringfield$394K
- Carl HenningsonManasquan$349K
- Anthony BottiLivingston$275K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.